Sinoporphyrin Sodium

华卟啉钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameSinoporphyrin Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursPeripheral Arterial DiseaseAtherosclerosis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical ScienceQinglong High-Scientific Technique Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Guangsheng Biopharmaceutical Co LtdShanghai Guangsheng Pharmaceutical Co LtdPeking University +[4] 
Inactive CompaniesHarbin Medical UniversityTsinghua University
Active IndicationsSquamous Intraepithelial Lesions of the CervixEsophageal NeoplasmsBiliary Tract Neoplasms +[4] 
Inactive IndicationsSolid tumoursPeripheral Arterial DiseaseAtherosclerosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A